17.500
+9,38%
2026-10-16
Fundamental Analysis
81 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +97.8% | +58.3% | 2 / 3 | +45.2% | +2.13 pp | +17.95 pp | +13.5% | 0.00 | 9.74 | 125 | +45,2% | 84,4 | +97,8% | 9.74 | 17.02 | −42,8% |
| Pts | 12 | 12 | 8 | 12 | 8 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 17.500 (close price on 2026-10-16)EPS (TTM): 1.797
Financial charts
1.Revenue & growth
VND bn125Q2/26
1.Revenue & growth
VND bn125Q2/26
2.Profit & growth
VND bn86,0Q2/26
3.Profit mix (Penman)
VND bn224Q2/26
4.Margins & cost structure
%25.8%Q2/26
5.Returns & cash cycle
% · days5.5%Q2/26
6.Earnings quality & cash
VND bn102Q2/26
7.Asset structure
VND bn1.776Q2/26
8.Funding & debt health
VND bn · times1.776Q2/26
9.Revenue backlog
VND bn4,62Q2/26
10.Valuation
times · %9,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %765Q2/26
Adjusted EPS growth, latest quarter
102%
Average adjusted EPS growth, 3 quarters
59.5%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26